Raptor Pharmaceutical Corp is a development-stage biotechnology Company which is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics.


Updates from The Motley Fool

Latest updates on Raptor Pharmaceutical from Fool.com.
This Week in Biotech

Five biotech companies received positive news this week, and four had Europe's review panel to th...

This Week in Biotech

Two FDA approvals, a pulled marketing application in the EU, unconvincing clinical results, and a...



Stock Performance

View Interactive RPTP Charts
Sponsored by

Key Data Points

Primary metrics and data points about Raptor Pharmaceutical.
Current Price: $9.00
Prev Close: $9.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $766M
P/E (ttm): 0.00
EPS (ttm): ($0.86)
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Julie Anne Smith, CEO

41% Approve

Based on 7 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Raptor Pharmaceutical.

Raptor Pharmaceutical Corp is a development-stage biotechnology Company which is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers